243 related articles for article (PubMed ID: 23725016)
1. E-cadherin autoantibody profile in patients with pemphigus vulgaris.
Oliveira ME; Culton DA; Prisayanh P; Qaqish BF; Diaz LA
Br J Dermatol; 2013 Oct; 169(4):812-8. PubMed ID: 23725016
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin is an additional immunological target for pemphigus autoantibodies.
Evangelista F; Dasher DA; Diaz LA; Prisayanh PS; Li N
J Invest Dermatol; 2008 Jul; 128(7):1710-8. PubMed ID: 18219275
[TBL] [Abstract][Full Text] [Related]
3. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
4. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
6. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
7. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
8. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
10. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
[TBL] [Abstract][Full Text] [Related]
11. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
[TBL] [Abstract][Full Text] [Related]
12. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
[TBL] [Abstract][Full Text] [Related]
13. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
14. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
[TBL] [Abstract][Full Text] [Related]
17. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
Koopai M; Mortazavi H; Khatami A; Khodashenas Z
Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
